– UK, Leeds – Surgical Innovations Group Plc (LON: SUN), the designer, manufacturer, and distributor of innovative technology for minimally invasive surgery, today announced the appointment of Keyvan Djamarani to its Board as an Independent Non-Executive Director with immediate effect.
“I am also delighted to welcome Keyvan to the Board. He has an excellent track record in the medical device sector and brings with him a broad and relevant skillset. His extensive operational experience will provide a wealth of expertise to the Board, affording valuable insight into the challenges of manufacturing as the Company undertakes a major efficiency drive to improve margins.” said Board Chair, Jonathan Glenn.
Concurrently, previous Board Chair Nigel Rogers will step down from the Board with immediate effect,
About Keyvan Djamarani
Keyvan Djamarani has over 30 years of relevant experience, holding numerous leadership roles in product development within manufacturing organizations covering medical and pharmaceutical drug delivery devices. He has a track record of delivering increased sales, profitability, and business-critical programs and projects. Most recently he spent over nine years as Managing Director/Business President at Bespak Europe, a medical and pharmaceutical drug delivery devices business. Keyvan began his career at Unilever working in their Detergents and Personal Products Divisions before joining Bespak. At Bespak, Keyvan held several roles across their European and North American divisions. Within this period, from 2002 to 2005, Keyvan was General Manager and President of Bespak Inc. and from 2010 to 2013, Keyvan became CEO of King Systems, an airways management business, encompassing design, development, and manufacture of airway management products. Keyvan was most recently a Non-executive Director of CEME Ltd, a not-for-profit business enterprise operating on a 19-acre campus, home to over 100 engineering, technology, and training businesses – a role he held for over 16 years.
About Surgical Innovations Group plc
The Group specializes in the design, manufacture, sale, and distribution of innovative, high-quality medical products, primarily for use in minimally invasive surgery. Our product and business development is guided and supported by a key group of nationally and internationally renowned surgeons across the spectrum of minimally invasive surgical activity.
We design manufacture and source our branded port access systems, surgical instruments, and retraction devices which are sold directly in the UK home market through our subsidiary, Elemental Healthcare, and exported widely through a global network of trusted distribution partners. Many of our products in this field are based on a “responsible” concept, in which the products are part reusable, part disposable, offering a high quality and environmentally responsible solution at a cost that is competitive against fully disposable alternatives.
Elemental also has exclusive UK distribution for a select group of specialist products employed in laparoscopy, bariatric and metabolic surgery, hernia repair, and breast reconstruction.
In addition, we design and develop medical devices for carefully selected OEM partners and have also collaborated with a major UK industrial partner to provide precision engineering solutions to complex problems outside the medical arena.
We aim for our brands to be recognized and respected by healthcare professionals in all major geographical markets in which we operate and provide by development, partnership, or acquisition a broad portfolio of cost-effective, procedure-specific surgical instruments and implantable devices that offer reliable solutions to genuine clinical needs in the operating theatre environment.
SOURCE: https://www.surginno.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.